Our data demonstrate a role for miR-622 in repressing metastasis via inhibition of HIF-1α-related EMT signaling and thus suggest that miR-622 could be utilized as a promising target for the development of a lung cancer therapeutic. This evidence concerns the gene HIF1A and lung cancer.